| Primary |
| Dermatitis Atopic |
36.9% |
| Eczema |
18.2% |
| Product Used For Unknown Indication |
17.5% |
| Vitiligo |
6.4% |
| Psoriasis |
2.7% |
| Dermatitis |
2.5% |
| Lichen Planus |
2.5% |
| Drug Use For Unknown Indication |
1.8% |
| Seborrhoeic Dermatitis |
1.7% |
| Pyoderma Gangrenosum |
1.1% |
| Graft Versus Host Disease |
1.0% |
| Dermatitis Contact |
0.9% |
| Neurodermatitis |
0.9% |
| Prurigo |
0.9% |
| Rash |
0.9% |
| Hypertension |
0.9% |
| Oral Lichen Planus |
0.9% |
| Rash Papular |
0.8% |
| Skin Disorder |
0.8% |
| Pruritus |
0.7% |
|
| Off Label Use |
25.2% |
| Skin Papilloma |
19.0% |
| Lymphoma |
6.5% |
| Squamous Cell Carcinoma |
6.0% |
| Hodgkin's Disease |
5.5% |
| Kaposi's Varicelliform Eruption |
4.7% |
| Non-hodgkin's Lymphoma |
3.9% |
| Basal Cell Carcinoma |
3.4% |
| T-cell Lymphoma |
3.1% |
| B-cell Lymphoma |
2.9% |
| Mycosis Fungoides |
2.6% |
| Lentigo |
2.3% |
| Malignant Melanoma |
2.3% |
| Squamous Cell Carcinoma Of Skin |
2.1% |
| Weight Decreased |
2.1% |
| Breast Cancer Female |
1.8% |
| Lymphadenopathy |
1.8% |
| Skin Infection |
1.8% |
| Application Site Pain |
1.6% |
| Drug Ineffective |
1.6% |
|
| Secondary |
| Eczema |
32.9% |
| Product Used For Unknown Indication |
11.1% |
| Drug Use For Unknown Indication |
9.9% |
| Dermatitis Atopic |
9.2% |
| Vitiligo |
5.5% |
| Hodgkin's Disease |
4.6% |
| Pain |
3.7% |
| Psoriasis |
3.2% |
| Chronic Graft Versus Host Disease |
2.5% |
| Graft Versus Host Disease |
2.1% |
| Bipolar Disorder |
1.8% |
| Chemotherapy |
1.8% |
| Pruritus |
1.6% |
| Sarcoidosis |
1.6% |
| Transplant |
1.6% |
| Diarrhoea |
1.4% |
| Eyelids Pruritus |
1.4% |
| Glaucoma |
1.4% |
| Medical Diet |
1.4% |
| Hypertension |
1.2% |
|
| Swelling |
15.7% |
| Off Label Use |
13.0% |
| Vomiting |
10.2% |
| Weight Increased |
9.3% |
| White Blood Cell Count Increased |
7.4% |
| Non-hodgkin's Lymphoma |
4.6% |
| Upper Respiratory Tract Infection |
4.6% |
| Vasogenic Cerebral Oedema |
4.6% |
| Breast Cancer |
2.8% |
| Hodgkin's Disease |
2.8% |
| Injury |
2.8% |
| Mastectomy |
2.8% |
| Nephroblastoma |
2.8% |
| Oropharyngeal Pain |
2.8% |
| Respiratory Failure |
2.8% |
| Squamous Cell Carcinoma Of The Cervix |
2.8% |
| Tumour Excision |
2.8% |
| Blood Potassium Decreased |
1.9% |
| Drug Prescribing Error |
1.9% |
| Drug Toxicity |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.0% |
| Psoriasis |
16.8% |
| Eczema |
8.0% |
| Drug Use For Unknown Indication |
7.3% |
| Dermatitis Atopic |
5.7% |
| Hypertension |
3.7% |
| Gastrooesophageal Reflux Disease |
3.5% |
| Crohn's Disease |
3.5% |
| Pain |
3.0% |
| Gastrointestinal Motility Disorder |
2.6% |
| Depression |
2.3% |
| Acne |
2.3% |
| Psoriatic Arthropathy |
2.2% |
| Vitiligo |
2.0% |
| Anxiety |
1.8% |
| Asthma |
1.6% |
| Diabetes Mellitus |
1.5% |
| Arthritis |
1.1% |
| Fibromyalgia |
1.1% |
| Rheumatoid Arthritis |
1.1% |
|
| Weight Increased |
9.7% |
| Skin Ulcer |
7.1% |
| Thyroid Neoplasm |
7.1% |
| Visual Acuity Reduced |
6.2% |
| Weight Decreased |
6.2% |
| Injection Site Pain |
5.3% |
| Psoriasis |
5.3% |
| Vision Blurred |
5.3% |
| Vomiting |
5.3% |
| Pain |
4.4% |
| Pancreatitis |
4.4% |
| Rash |
4.4% |
| White Blood Cell Count Decreased |
4.4% |
| Death |
3.5% |
| Nephrogenic Systemic Fibrosis |
3.5% |
| Red Blood Cell Count Decreased |
3.5% |
| Somnolence |
3.5% |
| Swelling Face |
3.5% |
| Upper-airway Cough Syndrome |
3.5% |
| Uterine Leiomyoma |
3.5% |
|
| Interacting |
|
| Atrial Fibrillation |
100.0% |
|
